Literature DB >> 15960924

[Bacteraemia risk criteria in the paediatric febrile neutropenic cancer patient].

Sandra Gala Peralta1, Teresa Cardesa Salzman, Juan José García García, Jesús Estella Aguado, Amadeu Gené Giralt, Carles Luaces Cubells.   

Abstract

INTRODUCTION: Cancer patients with febrile neutropenia are not a homogeneous group with respect to risk of bacterial infections. Some authors have proposed that febrile cancer patients with low risk factors of bacteraemia could be managed at home with domiciliary antibiotic treatment. The objectives are: to determine the incidence of bacteraemia in our cancer patients who have febrile neutropenia; and to identify the low-risk factors so that the patients can be managed at home using domiciliary antibiotic treatment.
MATERIAL AND METHODS: Clinical review of paediatric haemato-oncology disease admitted to our hospital in 2002 suffering from febrile neutropenia.
RESULTS: We describe a total of 62 episodes of febrile neutropenia in 30 patients; 24 episodes in haematology patients and 38 episodes in oncology patients. High-risk criteria are age <1 year, poor bone-marrow recovery, chemotherapy within 10 days of the episode, rapid fast neutropenia, leukaemia in relapse, uncontrolled solid cancer, and cardiac or nephrology disease. Based on the number of risk-factors, patients with two or less risk-factors have an incidence of bacteraemia of 6.7% (1/16) and patients with three or more risk factors have an incidence of bacteraemia of 32.6% (15/46); p<0.05.
CONCLUSIONS: Incidence of bacteraemia is similar to the reviewed literature; probability of bacteraemia increases with the number of individual risk factors, and patients with low risk of bacteraemia could be managed on an outpatient basis using domiciliary antibiotic treatment.

Entities:  

Mesh:

Year:  2005        PMID: 15960924     DOI: 10.1007/bf02708754

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  11 in total

1.  Trends in infection morbidity in a pediatric oncology ward, 1986-1995.

Authors:  G Wehl; F Allerberger; A Heitger; B Meister; K Maurer; F M Fink
Journal:  Med Pediatr Oncol       Date:  1999-05

2.  Evaluation of risk prediction criteria for episodes of febrile neutropenia in children with cancer.

Authors:  Sarah W Alexander; Kelly C Wade; Patricia L Hibberd; Susan K Parsons
Journal:  J Pediatr Hematol Oncol       Date:  2002-01       Impact factor: 1.289

3.  Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia.

Authors:  E P Baorto; V M Aquino; C A Mullen; G R Buchanan; M R DeBaun
Journal:  Cancer       Date:  2001-08-15       Impact factor: 6.860

4.  Ceftriaxone monotherapy in the treatment of low-risk febrile neutropenia.

Authors:  M Karthaus; H H Wolf; D Kämpfe; G Egerer; J Ritter; G Peters; T Südhoff; A Franke; G Heil; K H Kullmann; H Jürgens
Journal:  Chemotherapy       Date:  1998 Sep-Oct       Impact factor: 2.544

5.  Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection.

Authors:  Roland A Ammann; Andreas Hirt; Annette Ridolfi Lüthy; Christoph Aebi
Journal:  Med Pediatr Oncol       Date:  2003-11

6.  A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteremia.

Authors:  M M Mustafa; V M Aquino; A Pappo; I Tkaczewski; G R Buchanan
Journal:  J Pediatr       Date:  1996-06       Impact factor: 4.406

7.  [Meropenem therapy in children with febrile neutropenia].

Authors:  Judit Müller; Gábor Kovács; Miklós Garami; Marianne Schmidt; György Fekete
Journal:  Orv Hetil       Date:  2003-10-26       Impact factor: 0.540

8.  Early lymphopenia as a risk factor for chemotherapy-induced febrile neutropenia.

Authors:  Chul Won Choi; Hwa Jung Sung; Kyong Hwa Park; So Young Yoon; Seok Jin Kim; Sang Cheul Oh; Jae Hong Seo; Byung Soo Kim; Sang Won Shin; Yeul Hong Kim; Jun Suk Kim
Journal:  Am J Hematol       Date:  2003-08       Impact factor: 10.047

Review 9.  Evolving concepts of management of febrile neutropenia in children with cancer.

Authors:  Elmar Orudjev; Beverly J Lange
Journal:  Med Pediatr Oncol       Date:  2002-08

10.  The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis.

Authors:  K G Lucas; A E Brown; D Armstrong; D Chapman; G Heller
Journal:  Cancer       Date:  1996-02-15       Impact factor: 6.860

View more
  2 in total

1.  Epidemiology and characteristics of febrile neutropenia in oncology patients from Spanish tertiary care hospitals: PINNACLE study.

Authors:  Javier DE Castro Carpeño; Pere Gascón-Vilaplana; Ana Maria Casas-Fernández-DE Tejerina; Antonio Antón-Torres; Rafael López-López; Agustí Barnadas-Molins; Juan Jesús Cruz-Hernández; Bartomeu Massuti-Sureda; Carlos Camps-Herrero; Enrique Aranda-Aguilar; Francisco José Rebollo Laserna
Journal:  Mol Clin Oncol       Date:  2015-03-05

Review 2.  Systematic review and meta-analysis of the discriminatory performance of risk prediction rules in febrile neutropaenic episodes in children and young people.

Authors:  Bob Phillips; Ros Wade; Lesley A Stewart; Alex J Sutton
Journal:  Eur J Cancer       Date:  2010-11       Impact factor: 9.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.